These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31410511)

  • 1. [Stereotactic ablative radiotherapy confirmed as a standard technique in NSCLC stage I].
    Hecht M; Fietkau R
    Strahlenther Onkol; 2019 Oct; 195(10):945-948. PubMed ID: 31410511
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereotactic ablative radiotherapy for inoperable stage I NSCLC.
    Andratschke N
    Lancet Oncol; 2012 Aug; 13(8):746-8. PubMed ID: 22727221
    [No Abstract]   [Full Text] [Related]  

  • 3. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
    Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
    Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
    Abbas G; Danish A; Krasna MJ
    Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative radiation therapy for primary lung tumors.
    Heinzerling JH; Kavanagh B; Timmerman RD
    Cancer J; 2011; 17(1):28-32. PubMed ID: 21263264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiation oncologist's and thoracic surgeon's view on the role of stereotactic ablative radiotherapy for operable lung cancer.
    Timmerman RD; Fernando HC
    Semin Thorac Cardiovasc Surg; 2013; 25(1):8-13. PubMed ID: 23800524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
    Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
    Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should We Use the Olympic Spirit in the Controversy Between Surgery and Stereotactic Ablative Radiotherapy in Operable Early-Stage Non-Small Cell Lung Cancer?
    Bertolaccini L; Spaggiari L
    Ann Thorac Surg; 2020 Jul; 110(1):235. PubMed ID: 32277882
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options.
    Boujelbene N; Elloumi F; Kamel ME; Abeidi H; Matzinger O; Mirimanoff RO; Khanfir K
    Swiss Med Wkly; 2013; 143():w13780. PubMed ID: 23740331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.
    Chang JY; Bezjak A; Mornex F;
    J Thorac Oncol; 2015 Apr; 10(4):577-85. PubMed ID: 25514807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the reported clinical outcomes with stereotactic ablative radiotherapy generalizable?
    Senan S; Senthi S
    J Thorac Oncol; 2013 Aug; 8(8):995-6. PubMed ID: 23857397
    [No Abstract]   [Full Text] [Related]  

  • 12. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
    Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
    Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.
    Soldà F; Lodge M; Ashley S; Whitington A; Goldstraw P; Brada M
    Radiother Oncol; 2013 Oct; 109(1):1-7. PubMed ID: 24128806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracranial stereotactic body radiotherapy for stage I non-small cell lung cancer: still investigational or standard of care?
    Ball D
    J Thorac Oncol; 2008 Nov; 3(11):1209-10. PubMed ID: 18978553
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of Stage I Lung Cancer with Stereotactic Ablative Radiation Therapy.
    Dan T; Williams NL
    Surg Oncol Clin N Am; 2017 Jul; 26(3):393-403. PubMed ID: 28576179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.
    Phillips I; Sandhu S; Lüchtenborg M; Harden S
    Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):681-687. PubMed ID: 31377081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy?
    D'Angelillo RM; Ramella S
    J Thorac Oncol; 2018 Oct; 13(10):1441-1442. PubMed ID: 30244851
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship Between Tumor Location and Outcome in Patients With Early-Stage Lung Cancer.
    Dahele M; Damhuis RA
    Clin Lung Cancer; 2017 Sep; 18(5):e367-e368. PubMed ID: 28522159
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereotactic body radiotherapy for stage I NSCLC: the challenge of evidence-based medicine.
    Guckenberger M
    J Thorac Oncol; 2014 Feb; 9(2):e17-8. PubMed ID: 24419429
    [No Abstract]   [Full Text] [Related]  

  • 20. [Stereotactic radiotherapy is established treatment in localized non-small cell lung cancer].
    Sailas L; Virsunen H
    Duodecim; 2016; 132(6):571-5. PubMed ID: 27132296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.